NCT00000764View on ClinicalTrials.gov

Chemoprevention of Anal Neoplasia Arising Secondary to Anogenital Human Papillomavirus Infection in Persons With HIV Infection.

PHASE1CompletedINTERVENTIONAL

Enrollment

98

Participants

Timeline

Start Date

Not specified

Study Completion Date

July 31, 1996

Conditions

HIV InfectionsAnus Neoplasms

Interventions

DRUG

Isotretinoin

DRUG

Interferon alfa-2a

Trial Locations (1)

98122

University of Washington AIDS CRS, Seattle

All Listed Sponsors

collaborator

Hoffmann-La Roche

INDUSTRY

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH